Valuation : OraSure Technologies, Inc.

Market Cap 26Cr 22Cr 21Cr 19Cr 35Cr 2.44TCr 36Cr 243.5Cr 95Cr 1.23TCr 96Cr 94Cr 4.08TCr P/E 2026 *
-5.62x
P/E 2027 * -4.58x
Enterprise Value 26Cr 22Cr 21Cr 19Cr 35Cr 2.44TCr 36Cr 243.5Cr 95Cr 1.23TCr 96Cr 94Cr 4.08TCr EV / Sales 2026 *
2.1x
EV / Sales 2027 * 1.92x
Free-Float
93.63%
Yield 2026 *
-
Yield 2027 * -
1 day-0.54%
1 week-1.34%
Current month-8.89%
1 month-6.82%
3 months-7.29%
6 months+17.14%
Current year+52.48%
1 week 3.65
Extreme 3.65
3.93
1 month 3.65
Extreme 3.65
4.24
Current year 2.33
Extreme 2.33
4.58
1 year 2.08
Extreme 2.08
4.58
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
13.57
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 04/06/2022
Director of Finance/CFO 54 08/08/2022
Chief Tech/Sci/R&D Officer - 01/12/2024
Director TitleAgeSince
Director/Board Member 59 01/06/2020
Director/Board Member 66 08/11/2021
Director/Board Member 52 04/06/2022
Date Insider Type Main position Quantity % Market Cap.
01/03/26 Free

Controller/Auditor

72,044 0.1004%
01/03/26 Free

Chief Executive Officer

6,63,267 0.9246%
01/03/26 Free

Chief Financial Officer

1,43,546 0.2001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%-1.34%+10.48%-44.51% 26Cr
-2.20%-2.48%-15.20%+7.08% 20TCr
-2.23%-4.42%-2.40%+9.47% 12TCr
-2.00%+1.30%+10.88%+78.98% 6.26TCr
-2.00%-3.74%+27.02%+53.48% 5.24TCr
-1.09%+0.28%-3.06%-32.81% 5.18TCr
+0.37%-1.03%+16.90%-10.07% 3.36TCr
+0.20%+6.35% - - 3.03TCr
-1.09%-1.90%+41.55%-12.10% 2.46TCr
-0.47%+3.56%-3.25%+19.21% 2.38TCr
Average -0.91%-0.74%+9.21%+7.64% 5.95TCr
Weighted average by Cap. -1.35%-2.26%+0.30%+14.83%

Financials

2026 *2027 *
Net sales 12Cr 10Cr 9.81Cr 8.99Cr 17Cr 1.17TCr 17Cr 116.2Cr 45Cr 587.77Cr 46Cr 45Cr 1.95TCr 13Cr 11Cr 11Cr 9.8Cr 18Cr 1.27TCr 19Cr 126.76Cr 50Cr 641.18Cr 50Cr 49Cr 2.12TCr
Net income -4.62Cr -3.97Cr -3.71Cr -3.4Cr -6.4Cr -441.23Cr -6.42Cr -44Cr -17Cr -222.37Cr -17Cr -17Cr -735.97Cr -5.77Cr -4.95Cr -4.63Cr -4.24Cr -7.99Cr -550.64Cr -8.02Cr -55Cr -21Cr -277.52Cr -22Cr -21Cr -918.47Cr
Net Debt - -
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
28/26/28 $3.690 -0.54% 2,55,275
26/26/26 $3.710 -1.85% 2,49,984
25/26/25 $3.780 -1.05% 2,75,200
24/26/24 $3.820 -1.55% 3,48,092
21/26/21 $3.880 +3.74% 7,69,339
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.710USD
Average target price
4.000USD
Spread / Average Target
+7.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OSUR Stock